Hemo Alliance Newsletters

Legal Update, October 2020

Legal Update
The ABCs of Indirect Cost Rates
By Elizabeth "Issie" Karan 

HTCs often inquire with the Hemophilia Alliance regarding what is an appropriate “indirect cost rate.” I put this term in quotations because it goes by many names, facilities & administration fee, overhead charges, etc. Anytime I, as an amateur accountant, confer with true number crunchers, I find it important to make sure that we are discussing the same things. What I mean by “indirect cost rate” is the definition used by the Uniform Grants Guidance (UGG), codified at 45 CFR Part 75. However, what your grants manager, business manager, or pharmacy director means may differ. So, as you have internal conversation, I encourage you to make sure you are discussing the same costs.

Two important sets of rules govern how an HTC budgets and reconciles its books: the UGG and your organization’s rules. Sometimes the grant rules may be more prescriptive; other times your organization may have its own strict rules. As such, it is important to understand when and how both sets of rules govern your HTC’s operations.

As for “indirect cost rates”, the UGG defines the term differently for different types of grantees at §75.414. Major institutions of higher education are defined as those required to use the Standard Format for Submission as noted in appendix III to part 75.C. 11. Major nonprofit organizations are those which receive more than $10 million dollars in direct Federal funding.

For major institutions of higher education and major organizations, indirect (F&A) costs must be classified within two broad categories: “Facilities” and “Administration.” “Facilities” is defined as depreciation on buildings, equipment and capital improvement, interest on debt associated with certain buildings, equipment and capital improvements, and operations and maintenance expenses. “Administration” is defined as general administration and general expenses such as the director's office, accounting, personnel and all other types of expenditures not listed specifically under one of the subcategories of “Facilities” (including cross allocations from other pools, where applicable). For nonprofit organizations, library expenses are included in the “Administration” category; for institutions of higher education, they are included in the “Facilities” category.

Because of the diverse characteristics and accounting practices of nonprofit organizations, the UGG states that it is not possible to specify the types of cost which may be classified as indirect (F&A) cost in all situations. Identification with a Federal award rather than the nature of the goods and services involved is the determining factor in distinguishing direct from indirect (F&A) costs of Federal awards. However, typical examples of indirect (F&A) cost for many nonprofit organizations may include depreciation on buildings and equipment, the costs of operating and maintaining facilities, and general administration and general expenses, such as the salaries and expenses of executive officers, personnel administration, and accounting.

As for general rules of thumb for indirect cost rates, please see this letter from the Maternal and Child Health Bureau to then Program Directors of the MCHB Hemophilia Regional Grant, describing how HTCs should approach indirect cost rates. Additionally, this letter from the Maternal and Child Health Bureau, dated 1996 stating that the average indirect cost rate charged to HTCs was approximately 8.25%.

Also in this Issue…

Notes from Joe
· Improving Access to Care While Lowering Costs

Washington Update

Payer Update
· Payer Trends: What You Need to Know

Alliance Update
· Community Relations Update – October 2020
· Join Our Growing Hemophilia Alliance Team
· 2021 Meeting Schedule

Team Alliance Contact Information

We work for you! Please don’t hesitate to contact any of us with any questions or concerns:

Name Email Phone
Jeff Blake jeff@hemoalliance.org 317-657-5913
Jennifer Borrillo, MSW, LCSW, MBA borrillo@hemoalliance.org 504-376-5282
Heidi Lane, PT, DPT, PCS heidi@hemoalliance.org 435-659-1230
Angela Blue, MBA angela@hemoalliance.org 651-308-3902
Karen Bowe-Hause karen@hemoalliance.org 717-571-0266
Jazzmine Brown, MBA, MSW, LCSW jazzmine@hemoalliance.org 770-570-2649
Ashley Castello, MEd ashley@hemoalliance.org 225-266-5062
Zack Duffy zack@hemoalliance.org 503-804-2581
Michael B. Glomb MGlomb@ftlf.com 202-466-8960
Johanna Gray, MPA jgray@artemispolicygroup.com 703-304-8111
Kiet Huynh kiet@hemoalliance.org 917-362-1382
Elizabeth Karan elizabeth@karanlegalgroup.com 612-202-3240
Kollet Koulianos, MBA kollet@hemoalliance.org 309-397-8431
Roland P. Lamy, Jr. roland@hemoalliance.org 603-491-0853
Julie Lichterman julie@hemoalliance.org 941-779-5971
Dr. George L. Oestreich, Pharm.D., MPA george@gloetal.com 573-230-7075
Theresa Parker theresa@hemoalliance.org 727-688-2568
Mark Plencner mark@hemoalliance.org 701-318-2910
Ellen Riker eriker@artemispolicygroup.com 202-257-6670